Timing of Breast Cancer Related Lymphedema Development Over 3 Years: Observations from a Large, Prospective Randomized Screening Trial Comparing Bioimpedance Spectroscopy (BIS) Versus Tape Measure

Muscle Over Weight: What Every Cancer Patient Should Know About the New Era of Weight-Loss Medicine

Learn more

Maureen McBeth on GLP-1s, Muscle Loss and Bioelectrical Impedance Spectroscopy (BIS)

Learn more

ImpediMed Medical Bioimpedance Spectroscopy Devices

SOZO® Digital Health Platform Receives FDA Clearance for Sarcopenia Risk Assessment

Learn more

What Happens After Breast Cancer Surgery? Why the Next Conversation Matters

Learn more

The Silent Threat — Why Early Lymphedema Detection Matters for Breast Cancer Survivors

Learn more

Muscle Mass is a Key Metric in Cancer Care and GLP-1 Therapy

Learn more

ImpediMed Medical Bioimpedance Spectroscopy Devices

ImpediMed Broadens Breast Cancer Survivorship Monitoring with the SOZO® Digital Health Platform at ASBrS 2026

Learn more

9 Things I Wish I’d Known Before My Breast Cancer Surgery

Learn more

Expert Dr. Sheri Prentiss Discusses Early Lymphedema Risk Assessment

Learn more

ImpediMed Medical Bioimpedance Spectroscopy Devices

ImpediMed Appoints Erik Anderson as Chief Executive Officer

Learn more

Why measuring muscle mass matters more than tracking your weight [PODCAST]

Learn more

Why Long-Term Survivorship Demands Longitudinal Monitoring

Learn more

Contact Us Learn More About SOZO Digital Health Platform